Healthcare companies across APEC have made big moves to strengthen their resilience in 2023. As a follow-up to our study last year, this latest report provides fresh results to uncover the state of supply chain resilience in 2024, and points how there has been both progress and areas of attention.
Resilience remains critical, but healthcare companies in APEC are focusing on immediate priorities
Our latest results reveal a need for further action. Resilience indicators saw a noticeable 14-percentage point drop, indicating a shift in priorities on the corporate agenda of most healthcare manufacturing firms. Macroeconomic trends such as inflationary pressures, higher capital costs, and geopolitical risks could have led to this. However, it is worth noting that resilience levels today are markedly better since the early days of the COVID-19 era.
Leading businesses and policymakers should continue to support building resilience in supply chains
Healthcare businesses must continue to build resilience as part of a long-term strategy, rather than as a reactionary solution. At the same time, policymakers must work together with industry to tackle systemic-level challenges – including prioritizing ground-up solutions, promoting regulatory harmonization, and to consider alternative models to coordinate global supply chains.
